Miriam Merad

Immunology Mount Sinai School of Medicine, New York, NY 
Immunology, General, Cell Biology
"Miriam Merad"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Upadhyay R, Boiarsky JA, Pantsulaia G, et al. (2020) A critical role for fas-mediated off-target tumor killing in T cell immunotherapy. Cancer Discovery
Rafiei A, Wilk CM, Helbling PM, et al. (2020) BRAFV 600E or mutant MAP2K1 human CD34+ cells establish Langerhans cell-like histiocytosis in immune-deficient mice. Blood Advances. 4: 4912-4917
Brown BD, Leader AM, Vilcek J, et al. (2020) "America First" Will Destroy U.S. Science. Cell
Vabret N, Britton GJ, Gruber C, et al. (2020) Immunology of COVID-19: Current State of the Science. Immunity
Maier B, Leader AM, Chen ST, et al. (2020) Author Correction: A conserved dendritic-cell regulatory program limits antitumour immunity. Nature
Maier B, Leader AM, Chen ST, et al. (2020) A conserved dendritic-cell regulatory program limits antitumour immunity. Nature. 580: 257-262
Martin JC, Chang C, Boschetti G, et al. (2019) Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy. Cell
Marshall N, Hutchinson K, Marron TU, et al. (2019) Anti-tumor T-cell homeostatic activation is uncoupled from homeostatic inhibition by checkpoint blockade. Cancer Discovery
Kana V, Desland FA, Casanova-Acebes M, et al. (2019) CSF-1 controls cerebellar microglia and is required for motor function and social interaction. The Journal of Experimental Medicine
Ruiz de Galarreta M, Bresnahan E, Molina-Sanchez P, et al. (2019) β-catenin activation promotes immune escape and resistance to anti-PD-1 therapy in hepatocellular carcinoma. Cancer Discovery
See more...